Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients

Saved in:
Bibliographic Details
Published inJournal of clinical microbiology Vol. 58; no. 8
Main Authors Harrington, Amanda, Cox, Brian, Snowdon, Jennifer, Bakst, Jonathan, Ley, Erin, Grajales, Patricia, Maggiore, Jack, Kahn, Stephen
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 23.07.2020
Subjects
Betacoronavirus - isolation & purification
Clinical Laboratory Techniques - methods
Coronavirus Infections - diagnosis
COVID-19
COVID-19 Testing
Humans
Letter to the Editor
Molecular Diagnostic Techniques - methods
Nasal Mucosa - virology
Nasopharynx - virology
Nucleic Acid Amplification Techniques - methods
Pandemics
Pneumonia, Viral - diagnosis
SARS-CoV-2
Special Issue
COVID-19
NAAT
point of care
diagnostic testing
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Feature-3
ObjectType-Undefined-2
ObjectType-Article-4
Citation Harrington A, Cox B, Snowdon J, Bakst J, Ley E, Grajales P, Maggiore J, Kahn S. 2020. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients. J Clin Microbiol 58:e00798-20. https://doi.org/10.1128/JCM.00798-20.
ISSN:0095-1137
1098-660X
DOI:10.1128/jcm.00798-20